Web Stats Provided By Google Analytics

Saturday, March 10, 2018

Regeneron, Sanofi Cut Heart Drug's Price as Trial Disappoints an hour ago

... to get this drug to the patients who will benefit the most," said George Yancopoulos, chief scientific officer at Tarrytown, New York-based Regeneron. The study included people who were at high risk of having heart problems since they had survived a ...
https://www.bloomberg.com/news/articles/2018-03-10/regeneron-sanofi-cut-heart-drug-s-price-as-trial-disappoints

No comments:

Post a Comment

Popular Tarrytown Roundup Posts